Medicines Co
MDCO
MDCO was delisted on the 3rd of January, 2020.
152 hedge funds and large institutions have $1.52B invested in Medicines Co in 2014 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 66 increasing their positions, 50 reducing their positions, and 19 closing their positions.
32% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 50
0% more funds holding
Funds holding: 152 → 152 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 19
23% less capital invested
Capital invested by funds: $1.97B → $1.52B (-$453M)
86% less call options, than puts
Call options by funds: $1.81M | Put options by funds: $13M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BM
Bridger Management
New York
|
+$31.7M |
| 2 |
SPC
Slate Path Capital
New York
|
+$27.3M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$10.5M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$8.8M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
PointState Capital
New York
|
-$36.3M |
| 2 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
-$17.4M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$14.5M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$10.4M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$6.08M |
MDCO Hedge Fund Activity: Q3 2014 in Review
152 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q3 2014, worth a combined $1.52B — down 23% from $1.97B a quarter earlier.
Fund positioning in MDCO was balanced in Q3 2014: 19 funds opened new positions, 19 closed out, 66 added to existing stakes and 50 trimmed.
The largest buyer was Bridger Management, adding an estimated $31.7M. The largest seller was PointState Capital, cutting an estimated $36.3M.
- 152 institutional investors held Medicines Co (MDCO) as of Q3 2014, unchanged from Q2 2014.
- Funds reported $1.52B of Medicines Co stock for Q3 2014, down 23% quarter-over-quarter.
- 19 funds opened new Medicines Co positions in Q3 2014 and 19 closed out, a net change of 0 holders.
- The largest Medicines Co buyer in Q3 2014 was Bridger Management, an estimated $31.7M added.
- The largest Medicines Co seller in Q3 2014 was PointState Capital, an estimated $36.3M sold.
Based on aggregated 13F filings for Q3 2014.